Adagio Medical Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 07/31/24 | FY 07/30/24 | FY 12/31/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0 | — | — | — | $300,000 |
| Cost of revenue | $684,000 | — | — | — | $1.3M |
| Selling, general & administrative | $10.6M | — | — | — | $11.5M |
| Research and development | $10.6M | — | — | — | $15.4M |
| Operating income | -$21.9M | — | — | — | -$27.9M |
| Interest expense | $2.9M | — | — | — | $1.7M |
| Pretax income | -$25.3M | — | — | — | -$36.6M |
| Income tax expense | $0 | $0 | — | — | $0 |
| Net income | -$25.1M | — | — | — | -$36.6M |
| Balance Sheet | |||||
| Cash and equivalents | $17.1M | $20.6M | — | — | $1.4M |
| Current assets | $20.1M | $25.3M | — | — | $5.2M |
| Total assets | $43.3M | $48.4M | — | — | $6.8M |
| Current liabilities | $8.2M | $7.8M | — | — | $47.2M |
| Total liabilities | $30.9M | $28.5M | — | — | $47.4M |
| Stockholders' equity | $12.4M | $19.9M | $73.0M | -$148.3M | -$132.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$19.0M | — | — | — | -$25.7M |
| Depreciation and amortization | $970,000 | — | — | — | $532,000 |
| Stock-based compensation | $1.5M | — | — | — | $442,000 |
| Capital expenditure | $374,000 | — | — | — | $333,000 |
| Free cash flow | -$19.4M | — | — | — | -$26.0M |
| Impairments | $0 | — | — | — | $0 |
Shares outstanding 22.2M · Free float 22.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.